Latest return on equity
Tarsus Pharmaceuticals Return on equity
Direct answer
Tarsus Pharmaceuticals's return on equity is -13.68%.
The verified market snapshot reports -13.68%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 7, 2026.
Get free Tarsus Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -13.68%
Explore related company data
View Tarsus Pharmaceuticals's market capitalizationView Tarsus Pharmaceuticals's price-to-book ratioView Tarsus Pharmaceuticals's 52-week price rangeView Tarsus Pharmaceuticals's revenue growthView Tarsus Pharmaceuticals's profit marginView Tarsus Pharmaceuticals's debt-to-equity ratioView all Tarsus Pharmaceuticals key metricsReturn to Tarsus Pharmaceuticals profile